Jyong Biotech Ltd. Deferred Tax Assets, in Process Research and Development
Jyong Biotech Ltd. (MENS) had Deferred Tax Assets, in Process Research and Development of $10.53 million as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2026-05-15
- 2025-12-31: Deferred Tax Assets, in Process Research and Development $10.53M.
- 2024-12-31: Deferred Tax Assets, in Process Research and Development $10.09M.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2025-12-31 | $10.53M 20-F · filed 2026-05-15 |
| 2024-12-31 | $10.09M 20-F · filed 2026-05-15 |